SCHEMBL20114042

SCHEMBL20114042

c1ccc(-c2ccc(-n3c4ccccc4c4cc(-c5ccc6c(c5)Sc5ccccc5N6c5ccccc5)ccc43)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.42
KDM4E B2RXH2 1/20 0.42
ATM Q13315 1/20 0.42
HDAC4 P56524 1/20 0.37
HDAC6 Q9UBN7 1/20 0.36
TSPO P30536 1/20 0.34
BCHE P06276 3/20 0.33
KMT2A Q03164 3/20 0.32
IL1R1 P14778 1/20 0.32
ALDH1A1 P00352 3/20 0.32
MEN1 O00255 2/20 0.32
ACHE P22303 2/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
CHRM3 P20309 1/20 0.32
SLC6A2 P23975 1/20 0.32
HTR2C P28335 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15470182 1.00 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4HDAC6
SCHEMBL20114282 1.00 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4HDAC6
SCHEMBL10309966 0.99 L3MBTL1 (0.43) L3MBTL1KDM4EATMHDAC4HDAC6
SCHEMBL20114386 0.99 L3MBTL1 (0.40) L3MBTL1KDM4EATMHDAC4HDAC6
SCHEMBL20114043 0.96 L3MBTL1 (0.45) L3MBTL1KDM4EATMHDAC4HDAC6
SCHEMBL10331693 0.96 L3MBTL1 (0.45) L3MBTL1KDM4EATMHDAC4HDAC6
SCHEMBL10331707 0.96 L3MBTL1 (0.45) L3MBTL1KDM4EATMHDAC4HDAC6
SCHEMBL15470183 0.96 L3MBTL1 (0.45) L3MBTL1KDM4EATMHDAC4HDAC6
SCHEMBL20114823 0.95 L3MBTL1 (0.40) L3MBTL1KDM4EATMHDAC4HDAC6
SCHEMBL20114271 0.95 ATM (0.37) L3MBTL1KDM4EATMHDAC4HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210280796-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2021-09-09 US disclosed
WO-2018080067-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING SAME 주식회사 두산 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210280796-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, ORGANIC ELECTROLUMINESCENT MATERIAL COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE OR10J3, ELAVL1, VDAC2 L3MBTL1 82/4885KDM4E 1212/4885ATM 2041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.